HARRISON, JAMES,FULLER, STEPHEN,BROWN, TOBIAS, JOSEF
申请号：
RSP20200849
公开号：
RS60551B1
申请日:
2015.01.05
申请国别(地区):
RS
年份:
2020
代理人:
摘要：
The present invention relates to oral pharmaceutical compositions comprising nitisinone, or a pharmaceutically acceptable salt thereof, their use in the treatment of tyrosinemia, such as Hereditary Tyrosinemia type-1 (HT-1), or alkaptonuria. The compositions have improved stability characteristics. The invention also relates to processes for producing nitisinone.
